Detection of West Nile Virus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7074555
APP PUB NO 20050244814A1
SERIAL NO

10834424

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method and device for detecting a West Nile Virus (WNV) infection including contacting a biological sample from a subject with an anti-IgM antibody and a recombinant WNV E polypeptide and detecting whether the polypeptide substantially binds to an antibody in the sample. The invention also includes a method and device for determining whether an animal is infected with West Nile Virus (WNV), or is either not infected or is vaccinated with a WNV vaccine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
IDEXX Laboratories, Inc.WESTBROOK, ME166

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chandrashekar, Ramaswamy Scarborough, ME 29 280
Esty, Katherine Jean Westbrook, ME 2 6

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (1)
2003/0148,261 Compositions and methods comprising West Nile virus polypeptides 16 2002
 
MERIAL LIMITED, REGISTERED IN ENGLAND AND WALES NO. 3332751, AND DOMESTICATED IN DELAWARE, USA AS MERIAL LLC, INCLUDING HAVING AN ADDRESS AT 3239 SATELLITE BLVD., DULUTH, GA 30096-4640 (1)
* 2004/0037,848 Recombinant vaccine against West Nile Virus 10 2003
 
MERIAL (1)
2003/0104,008 Recombinant vaccine against west nile virus 13 2002
 
CONOCO, INC. (1)
2003/0022,949 Fischer-tropsch processes and catalysts using polyacrylate matrix structures 1 2002
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
CRUCELL HOLLAND B.V. (11)
8052974 Host cell specific binding molecules capable of neutralizing viruses and uses thereof 5 2006
* 2010/0303,801 Host cell specific binding molecules capable of neutralizing viruses and uses thereof 5 2006
7537764 Binding molecules capable of neutralizing west nile virus and uses thereof 8 2006
* 2007/0042,359 Binding molecules capable of neutralizing west nile virus and uses thereof 6 2006
7244430 Binding molecules capable of neutralizing West Nile virus and uses thereof 12 2007
* 2007/0122,801 BINDING MOLECULES CAPABLE OF NEUTRALIZING WEST NILE VIRUS AND USES THEREOF 3 2007
8211431 Human binding molecules having killing activity against staphylococci and uses thereof 3 2007
* 2009/0104,204 Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof 14 2007
* 2009/0017,068 Vaccines against West Nile Virus 5 2008
8911738 Host cell specific binding molecules capable of neutralizing viruses and uses thereof 0 2011
8460666 Human binding molecules having killing activity against staphylococci and uses thereof 1 2012
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 11, 2018
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00